. 2020 Sep 13;4(1):e000717.

doi: 10.1136/bmjpo-2020-000717. eCollection 2020.

Consensus guidelines on managing Rett syndrome across the lifespan

Cary Fu¹, Dallas Armstrong^{2

3}, Eric Marsh^{2

3}, David Lieberman⁴, Kathleen Motil^{5

6}, Rochelle Witt⁴, Shannon Standridge^{7

8}, Paige Nues⁹, Jane Lane¹⁰, Tristen Dinkel¹¹, Monica Coenraads¹², Jana von Hehn¹², Mary Jones¹³, Katie Hale¹³, Bernhard Suter^{14

15}, Daniel Glaze^{14

15}, Jeffrey Neul^{16

17}, Alan Percy¹⁸, Timothy Benke^{11

19}

Affiliations

¹ Pediatrics and Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
² Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
³ Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
⁵ Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
⁶ Children's Nutrition Research Center, USDA ARS, Houston, Texas, USA.
⁷ Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
⁸ Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
⁹ International Rett Syndrome Foundation, Cincinnati, Ohio, USA.
¹⁰ Civitan International Research Center, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
¹¹ Neurology, Children's Hospital Colorado, Aurora, Colorado, USA.
¹² Rett Syndrome Research Trust, New York, New York, USA.
¹³ Pediatric Medicine, UCSF Benioff Children's Hospital Oakland, Oakland, California, USA.
¹⁴ Pediatrics and Neurology, Baylor College of Medicine, Houston, Texas, USA.
¹⁵ Neurology, Texas Children's Hospital, Houston, Texas, USA.
¹⁶ Vanderbilt Kennedy Center, Nashville, Tennessee, USA.
¹⁷ Pediatrics, Pharmacology, and Special Education, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
¹⁸ Pediatrics, Neurology, Neurobiology, Genetics, and Psychology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
¹⁹ Pediatrics, Pharmacology, Neurology, Otolaryngology, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

PMID: 32984552
PMCID: PMC7488790
DOI: 10.1136/bmjpo-2020-000717

Consensus guidelines on managing Rett syndrome across the lifespan

Cary Fu et al. BMJ Paediatr Open. 2020.

. 2020 Sep 13;4(1):e000717.

doi: 10.1136/bmjpo-2020-000717. eCollection 2020.

Authors

Affiliations

¹ Pediatrics and Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
² Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
³ Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
⁵ Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
⁶ Children's Nutrition Research Center, USDA ARS, Houston, Texas, USA.
⁷ Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
⁸ Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
⁹ International Rett Syndrome Foundation, Cincinnati, Ohio, USA.
¹⁰ Civitan International Research Center, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
¹¹ Neurology, Children's Hospital Colorado, Aurora, Colorado, USA.
¹² Rett Syndrome Research Trust, New York, New York, USA.
¹³ Pediatric Medicine, UCSF Benioff Children's Hospital Oakland, Oakland, California, USA.
¹⁴ Pediatrics and Neurology, Baylor College of Medicine, Houston, Texas, USA.
¹⁵ Neurology, Texas Children's Hospital, Houston, Texas, USA.
¹⁶ Vanderbilt Kennedy Center, Nashville, Tennessee, USA.
¹⁷ Pediatrics, Pharmacology, and Special Education, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
¹⁸ Pediatrics, Neurology, Neurobiology, Genetics, and Psychology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
¹⁹ Pediatrics, Pharmacology, Neurology, Otolaryngology, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

PMID: 32984552
PMCID: PMC7488790
DOI: 10.1136/bmjpo-2020-000717

Abstract

Background: Rett syndrome (RTT) is a severe neurodevelopmental disorder with complex medical comorbidities extending beyond the nervous system requiring the attention of health professionals. There is no peer-reviewed, consensus-based therapeutic guidance to care in RTT. The objective was to provide consensus on guidance of best practice for addressing these concerns.

Methods: Informed by the literature and using a modified Delphi approach, a consensus process was used to develop guidance for care in RTT by health professionals.

Results: Typical RTT presents early in childhood in a clinically recognisable fashion. Multisystem comorbidities evolve throughout the lifespan requiring coordination of care between primary care and often multiple subspecialty providers. To assist health professionals and families in seeking best practice, a checklist and detailed references for guidance were developed by consensus.

Conclusions: The overall multisystem issues of RTT require primary care providers and other health professionals to manage complex medical comorbidities within the context of the whole individual and family. Given the median life expectancy well into the sixth decade, guidance is provided to health professionals to achieve current best possible outcomes for these special-needs individuals.

Keywords: gastroenterology; genetics; neurology; rehabilitation; syndrome.

PubMed Disclaimer

Conflict of interest statement

Competing interests: EM: funding from the NIH and International Rett Syndrome Foundation; clinical trials with GW Pharmaceuticals, Zogenix and Marinus; consultancy to Stoke Therapeutics. DL: consultancy for AveXis; clinical trials with Acadia, Anavex and GW Pharmaceuticals. SS: speaker bureau for GW Pharmaceuticals. BS: funding from the NIH and Blue Bird Circle; clinical trials with Acadia. DG: funding from the NIH and Blue Bird Circle; clinical trials with GW Pharmaceuticals, Acadia, Anavex and Newron; consultancy for Acadia and Trend Community Pharmaceuticals. JN: funding from the NIH; consultancy with Acadia, AveXis, Biohaven, GW Pharmaceuticals, Kurro, Neuren, Newron, Ovid, Takeda and Teva. JL: funding from NIH; consultancy from International Rett Syndrome Foundation and GW Pharmaceuticals. AP: funding from the NIH; consultancy for Anavex, AveXis, Acadia and GW Pharmaceuticals; clinical trials with Anavex, Acadia, GW Pharmaceuticals and RSRT. TB: funding from the NIH, International Foundation for CDKL5 Research and Loulou Foundation; consultancy for AveXis, Ovid, GW Pharmaceuticals, International Rett Syndrome Foundation, Takeda and Marinus; clinical trials with Acadia, Ovid, GW Pharmaceuticals, Marinus and RSRT; all remuneration has been made to his department.

Cited by

Trofinetide: First Approval.
Keam SJ. Keam SJ. Drugs. 2023 Jun;83(9):819-824. doi: 10.1007/s40265-023-01883-8. Drugs. 2023. PMID: 37191913 Review.
Behavioral and Psychiatric Disorders in Syndromic Autism.
Genovese AC, Butler MG. Genovese AC, et al. Brain Sci. 2024 Mar 30;14(4):343. doi: 10.3390/brainsci14040343. Brain Sci. 2024. PMID: 38671997 Free PMC article. Review.
Women With Genetic Epilepsies.
Marques PT, Kaka N, Zulfiqar Ali Q, Rong M, Bui E, Andrade DM. Marques PT, et al. Neurol Genet. 2025 Feb 11;11(1):e200233. doi: 10.1212/NXG.0000000000200233. eCollection 2025 Feb. Neurol Genet. 2025. PMID: 39944415 Free PMC article. Review.
Conference proceedings: Inaugural meeting of the consortium for autism, genetic neurodevelopmental disorders, and digestive diseases.
Halladay A, Croffie J, Dallman J, Grabenstatter H, Holingue C, Madgett K, Margolis KG, Motil KJ, Jimenez-Gomez A, Ferguson BJ, Moshiree B, Still K, Williams K, Upp GR, Bennett W. Halladay A, et al. J Pediatr Gastroenterol Nutr. 2024 Nov;79(5):1062-1070. doi: 10.1002/jpn3.12360. Epub 2024 Sep 11. J Pediatr Gastroenterol Nutr. 2024. PMID: 39257288
Potentiation of group III metabotropic glutamate receptors positively affects neurophysiological features in a mouse model of Rett syndrome.
Dong HW, Weiss K, Dickerson JW, Meadows MJ, Zagol-Ikapitte I, Boutaud O, Rook JM, Neul JL, Niswender CM. Dong HW, et al. J Pharmacol Exp Ther. 2025 Jun;392(6):103602. doi: 10.1016/j.jpet.2025.103602. Epub 2025 May 8. J Pharmacol Exp Ther. 2025. PMID: 40446468 Free PMC article.

See all "Cited by" articles

References

1. Neul JL, Kaufmann WE, Glaze DG, et al. . Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010;68:944–50. 10.1002/ana.22124 - DOI - PMC - PubMed
1. Hagberg B. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 1985;74:405–8. 10.1111/j.1651-2227.1985.tb10993.x - DOI - PubMed
1. Armstrong DD. Rett syndrome neuropathology review 2000. Brain Dev 2001;23 Suppl 1:S72–6. 10.1016/S0387-7604(01)00332-1 - DOI - PubMed
1. Guy J, Gan J, Selfridge J, et al. . Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007;315:1143–7. 10.1126/science.1138389 - DOI - PMC - PubMed
1. Sinnett SE, Hector RD, Gadalla KKE, et al. . Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery. Mol Ther Methods Clin Dev 2017;5:106–15. 10.1016/j.omtm.2017.04.006 - DOI - PMC - PubMed

Grants and funding

U54 HD061222/HD/NICHD NIH HHS/United States

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Consensus guidelines on managing Rett syndrome across the lifespan

Affiliations

Consensus guidelines on managing Rett syndrome across the lifespan

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Related information

Grants and funding

LinkOut - more resources

Full Text Sources